SF3B3 and plasma cell myeloma: Since EZH2 is overexpressed in myeloma cells in association with a poor outcome [21,71], it would be interesting to explore the potential role of alternative EZH2 splicing regulated by SF3B3 in plasma cell tumorigenesis and disease progression.